0.00Open20.84Pre Close0 Volume0 Open Interest121.00Strike Price0.00Turnover3614.41%IV4.80%PremiumNov 22, 2024Expiry Date14.34Intrinsic Value100Multiplier-4DDays to Expiry6.50Extrinsic Value100Contract SizeAmericanOptions Type0.9979Delta0.0008Gamma6.49Leverage Ratio-24.7303Theta0.0000Rho6.48Eff Leverage0.0000Vega
NVIDIA Stock Discussion
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.
2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies...
after dinner rally let's gooooo
https://www.yahoo.com/tech/elon-musks-demands-nvidias-ai-162300867.html
No comment yet